135 related articles for article (PubMed ID: 32344318)
21. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
23. The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia.
Bilir C; Engin H; Can M; Temi YB; Demirtas D
Med Oncol; 2015 Mar; 32(3):56. PubMed ID: 25638467
[TBL] [Abstract][Full Text] [Related]
24. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of Cachexia in Head and Neck Cancer Patients Based on a Modified Glasgow Prognostic Score].
Matsuzuka T; Suzuki M; Saijoh S; Ikeda M; Imaizumi M; Nomoto Y; Matsui T; Tada Y; Omori K
Nihon Jibiinkoka Gakkai Kaiho; 2016 Feb; 119(2):125-8. PubMed ID: 27149710
[TBL] [Abstract][Full Text] [Related]
26. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer.
Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K
Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
[TBL] [Abstract][Full Text] [Related]
28. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
29. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.
Tokunaga R; Sakamoto Y; Nakagawa S; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2017 Aug; 22(4):740-748. PubMed ID: 28213742
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
31. Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer.
Leung EY; Crozier JE; Talwar D; O'Reilly DS; McKee RF; Horgan PG; McMillan DC
Int J Cancer; 2008 Nov; 123(10):2460-4. PubMed ID: 18729200
[TBL] [Abstract][Full Text] [Related]
32. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
[TBL] [Abstract][Full Text] [Related]
33. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.
Guthrie GJ; Charles KA; Roxburgh CS; Horgan PG; McMillan DC; Clarke SJ
Crit Rev Oncol Hematol; 2013 Oct; 88(1):218-30. PubMed ID: 23602134
[TBL] [Abstract][Full Text] [Related]
34. Systemic inflammation, cachexia and prognosis in patients with cancer.
Deans C; Wigmore SJ
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):265-9. PubMed ID: 15809528
[TBL] [Abstract][Full Text] [Related]
35. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
Nakayama M; Tabuchi K; Hara A
Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
[TBL] [Abstract][Full Text] [Related]
36. Inflammation and cancer: What a surgical oncologist should know.
Dupré A; Malik HZ
Eur J Surg Oncol; 2018 May; 44(5):566-570. PubMed ID: 29530345
[TBL] [Abstract][Full Text] [Related]
37. Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia.
Shirai Y; Okugawa Y; Hishida A; Ogawa A; Okamoto K; Shintani M; Morimoto Y; Nishikawa R; Yokoe T; Tanaka K; Urata H; Toiyama Y; Inoue Y; Tanaka M; Mohri Y; Goel A; Kusunoki M; McMillan DC; Miki C
Sci Rep; 2017 Jul; 7(1):4826. PubMed ID: 28684736
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of scores based on malnutrition or systemic inflammatory response in patients with metastatic or recurrent gastric cancer.
Sachlova M; Majek O; Tucek S
Nutr Cancer; 2014; 66(8):1362-70. PubMed ID: 25356861
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
[TBL] [Abstract][Full Text] [Related]
40. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
